LENZ Therapeutics, Inc.
USD7.13
-0.31 (-4.17%)
CEO
Evert Schimmelpennink
IPO Date
2024-03-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.30
Prev. Close
$7.44
Day Low
$6.85
Day High
$7.39
52W Low
$6.61
52W High
$50.40
Market Cap
$0.22B
Volume
0.63M
| 28,089 |
| $8.95 |
| 30 Mar 2026 | Chevallard Daniel R. | Chief Financial Officer | P-Purchase | Acquired | 7,500 | $8.57 |
| 6 Jan 2026 | Olsson Shawn | Chief Commercial Officer | A-Award | Acquired | 84,200 | $16.00 |
| 6 Jan 2026 | Olsson Shawn | Chief Commercial Officer | A-Award | Acquired | 14,000 | $0.00 |
| 6 Jan 2026 | Odrich Marc | Chief Medical Officer | A-Award | Acquired | 84,200 | $16.00 |
| 6 Jan 2026 | Odrich Marc | Chief Medical Officer | A-Award | Acquired | 14,000 | $0.00 |
| 6 Jan 2026 | Chevallard Daniel R. | Chief Financial Officer | A-Award | Acquired | 84,200 | $16.00 |
| 6 Jan 2026 | Chevallard Daniel R. | Chief Financial Officer | A-Award | Acquired | 14,000 | $0.00 |
| 6 Jan 2026 | Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | A-Award | Acquired | 358,100 | $16.00 |